7 citations,
July 2020 in “Journal of The American Academy of Dermatology” Skin symptoms linked to COVID-19 are hard to confirm, and more testing is needed to identify which are truly caused by the virus.
4 citations,
October 2020 in “Research Square (Research Square)” Hydroxychloroquine, nitazoxanide, and ivermectin were similarly effective in treating early COVID-19.
4 citations,
October 2020 in “Research Square (Research Square)” Early treatment with certain drug combinations improved COVID-19 outcomes and prevented severe disease in males, including those at higher risk.
[object Object] 3 citations,
May 2021 in “British Journal of Dermatology” The COVID-19 pandemic led to fewer skin checks and skin cancer diagnoses in Australia in 2020.
1 citations,
April 2021 in “Clinical and Experimental Dermatology” The COVID-19 pandemic has caused a 57% increase in interest in facial cosmetic procedures, leading to calls for better industry regulation and professional standards.
1 citations,
October 2020 in “Research Square (Research Square)” Men with male pattern baldness had worse COVID-19 symptoms, but early treatment with certain drugs improved outcomes for all.
April 2024 in “The Egyptian Family Medicine Journal/The Egyptian Family Medicine Journal ” Vitamin D supplements significantly improved post-COVID-19 symptoms in deficient patients.
February 2024 in “Psychoneuroendocrinology” The COVID-19 pandemic did not significantly change stress levels in preschoolers, but higher-income families' children showed higher stress.
December 2023 in “Health Information Jurnal Penelitian” Post-COVID syndrome causes long-lasting symptoms like fatigue, breathing issues, and anxiety.
April 2023 in “Journal of Investigative Dermatology” The COVID-19 pandemic caused a drop in phototherapy for skin conditions, with only 40% of vitiligo and psoriasis patients returning after a hospital closure in Taiwan.
July 2022 in “Hair transplant forum international” The COVID-19 pandemic affected hair restoration practices in 2022.
May 2022 in “International Journal of Dermatology” A woman experienced sudden hair graying and loss after a COVID-19 vaccine, which improved with treatment.
A person with a new mutation in the SCN1A gene developed brain inflammation after COVID-19.
November 2021 in “Open Forum Infectious Diseases” Some COVID-19 pneumonia patients in Veracruz, Mexico had rare skin issues like temporary hair loss linked to disease severity.
July 2021 in “International journal of innovative research in medical science” Some COVID-19 patients in Saudi Arabia had skin symptoms, with rashes being the most common.
March 2021 in “Clinical Medicine” A team of different healthcare experts is good for treating long-term COVID-19 issues.
December 2020 in “Dermatology archives” Some COVID-19 pneumonia patients in Veracruz, Mexico, had skin issues, with reversible hair loss linked to disease severity.
January 2020 in “DOAJ (DOAJ: Directory of Open Access Journals)” The COVID-19 pandemic caused most hair transplant surgeons in India to stop working, and many planned to change their safety measures afterwards.
October 2021 in “Journal of Investigative Dermatology” No significant link between male pattern baldness and severe Covid-19, but some shared biological pathways exist.
[object Object] 1 citations,
January 2021 in “Wits Journal of Clinical Medicine” Long COVID causes lasting symptoms and needs ongoing care.
April 2023 in “Journal of Investigative Dermatology” COVID-toes show a unique immune response over time, different from vaccine-related chilblains.
121 citations,
November 2020 in “Endocrine” Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.
91 citations,
July 2020 in “JAMA Dermatology” Minoxidil can improve hair growth in some patients with woolly hair due to LIPH variants, with varying responses and mild side effects.
71 citations,
April 2020 in “Journal of Cosmetic Dermatology” Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.
42 citations,
June 2020 in “Seminars in Oncology” Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.
41 citations,
February 2021 in “Cureus” Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.
34 citations,
September 2020 in “BMC Endocrine Disorders” Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.
31 citations,
August 2020 in “EClinicalMedicine” Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.